The identical director sales and the exercise-and-sell pattern by the CLO are consistent with routine portfolio management or tax planning, not a bearish signal. The broader insider selling trend is notable but has not historically predicted negative returns for SION. Monitor for any fundamental news (e.g., earnings, pipeline updates) that might explain the selling, but no immediate action is warranted.
SION drugs
SION drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 10 $45.29entry
- T+1 · 4mo ago −2.96%α −2.19% · $43.95
- T+5 · 4mo ago 0.00%α +0.56% · $45.29
- T+20 · 3mo ago +12.70%α +10.27% · $51.04
- T+60 · 6w ago −89.29%α −91.92% · $4.85
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three insiders at Sionna Therapeutics (SION) sold a total of $8.16M in shares over a 7-day window, representing 0.41% of the company's $2.0B market cap. Two directors sold identical amounts on the same day, suggesting a pre-arranged plan, while the Chief Legal Officer sold after exercising options. The selling is part of a broader trend of $18.7M in insider sales over the past 30 days, but insider sales are weak predictors of stock direction, and the cluster size is modest.
Key Financial Metrics
Key Facts
- Orbimed Advisors LLC (Director) sold 85,918 shares at $44.86 on 2026-07-07, netting $3.85M.
- Peter A. Thompson (Director) sold 85,918 shares at $44.86 on 2026-07-07, netting $3.85M.
- Jennifer Fitzpatrick (Chief Legal Officer) sold 10,250 shares at $43.60 on 2026-07-06, netting $447K, after exercising options.
- Total sale value of $8.16M is 0.41% of SION's $2.0B market cap.
- Identical director sales (same size, date, price) suggest a coordinated or 10b5-1 plan, reducing informational signal.
- Over the past 30 days, total insider sales at SION amount to $18.7M (approximately 0.94% of market cap).
Financial Impact
$8.16M in open-market insider sales (0.41% of market cap)
Risk Factors
- Further insider selling could increase and signal a loss of confidence.
- The broader selling trend may intensify if negative catalysts emerge.
- Lack of positive insider buying alongside sales reduces bullish conviction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SION-1783670491135 |
Track record
22 reports on SION
7 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +89.29% at T+60 after the Jul 9, 2026 report. 9 of 9 went positive at some point.
Filters
- Nov 10, 20266d ago Press Release Neutral 5/10 Entry $3.70 Now $3.12 −15.68% settles Nov 17
- Nov 9, 20267d ago SC 13G Neutral 3/10 Entry $3.57 to $3.12 Now $3.12 −12.61% ▼ −12.61% −10.91% vs SPY
- Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $3.65 to $3.70 Now $3.12 −14.52% ▲ +1.37% +1.96% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 3/10 Entry $6.02 to $5.15 Now $3.12 −48.17% ▼ −14.45% −13.26% vs SPY
- Sep 21, 20268w ago SC 13D/A Bearish 7/10 Entry $6.02 to $5.15 Now $3.12 +48.17% ▲ +14.45% +13.26% vs SPY
- Sep 17, 20268w ago 144 Bearish 5/10 Entry $5.96 to $5.23 Now $3.12 +47.65% ▲ +12.25% +13.52% vs SPY
- Aug 10, 202614w ago 8-K Bearish 7/10 Entry $4.50 to $5.91 Now $3.12 +30.67% ▼ −31.33% −31.38% vs SPY
- Aug 6, 202614w ago 8-K Neutral 4/10 Entry $49.61 to $6.54 Now $3.12 −93.71% ▼ −86.82% −88.03% vs SPY
- Jul 9, 202618w ago Insider Cluster Neutral 4/10 Viewing Entry $45.29 to $45.29 Now $3.12 −93.11% · 0.00% +0.56% vs SPY
- Jul 9, 202618w ago Insider Cluster Bearish 5/10 Entry $45.29 to $45.29 Now $3.12 +93.11% · 0.00% −0.56% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers